Nucleis

08-Sep-2005 | business & finance

RNAx and Nucleis announce a collaboration to co-market in vitro and in vivo shRNA target validation technology

Nucleis, a biotechnological company focused on the creation of custom made transgenic mice, and RNAx announced the signing of a non-exclusive co-marketing ...